CD163
CD163 | |||
---|---|---|---|
Identifiers | |||
Gene ontology | |||
Molecular function | |||
Cellular component | |||
Biological process | |||
Sources:Amigo / QuickGO |
Ensembl | |||||||||
---|---|---|---|---|---|---|---|---|---|
UniProt | |||||||||
RefSeq (mRNA) | |||||||||
RefSeq (protein) | |||||||||
Location (UCSC) | Chr 12: 7.47 – 7.5 Mb | Chr 6: 124.28 – 124.31 Mb | |||||||
PubMed search | [3] | [4] |
View/Edit Human | View/Edit Mouse |
CD163 (Cluster of Differentiation 163) is a
Structure
The molecular size is 130
kDa
. The receptor belongs to the scavenger receptor cysteine rich family type B and consists of a 1048 amino acid residues extracellular domain, a single transmembrane segment and a cytoplasmic tail with several splice variants.
Clinical significance
A soluble form of the receptor exists in plasma, and
Hodgkin Lymphoma.[16][17] sCD163 is also upregulated in cerebrospinal fluid after subarachnoid haemorrhage.[12] CD163 has recently been identified as expressed on neurons in the CNS following hemorrhage, although the significance of this is unclear.[18][19][20] The excretion of soluble CD163 into the urine is tightly associated with the presence of active glomerulonephritis in systemic lupus erythematosus and ANCA vasculitis and can be used to track response to therapy. [21]
Differences between mouse and human
Differences between mice and humans in CD163 biology are important to note since preclinical studies are frequently conducted in mice. sCD163 shedding occurs in humans but not mice, due to the emergence of an Arg-Ser-Ser-Arg sequence in humans, essential for enzymatic cleavage by ADAM17.[22] Human CD163, but not mouse CD163, exhibits a strikingly higher affinity to hemoglobin-haptoglobin complex compared to hemoglobin alone.[23]
Animal studies
Pigs with a section of the CD163 gene removed showed complete resistance to the virus that causes
Porcine Reproductive and Respiratory Syndrome.[24]
Interactions
CD163 has been shown to
See also
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000177575 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000008845 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Entrez Gene: CD163 CD163 molecule".
- S2CID 205012693.
- PMID 16189277.
- PMID 15491976.
- S2CID 4811741.
- PMID 20299103.
- PMID 19777868.
- ^ PMID 22380637.
- PMID 10066432.
- S2CID 38771947.
- S2CID 206174528.
- PMID 23224400.
- S2CID 42546891.
- PMID 26772987.
- PMID 28386733.
- PMID 28360115.
- PMID 26940094.
- PMID 24275664.
- PMID 22793784.
- PMID 28231264.
- PMID 11298324.
Further reading
- Ren H, Han R, Chen X, Liu X, Wan J, Wang L, Yang X, Wang J (May 2020). "Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update". J Cereb Blood Flow Metab. 40 (9): 1752–1768. PMID 32423330.
- Graversen JH, Madsen M, Moestrup SK (April 2002). "CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma". The International Journal of Biochemistry & Cell Biology. 34 (4): 309–14. PMID 11854028.
- Madsen M, Graversen JH, Moestrup SK (2002). "Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes". Redox Report. 6 (6): 386–8. PMID 11865982.
- Moestrup SK, Møller HJ (2005). "CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response". Annals of Medicine. 36 (5): 347–54. S2CID 32420894.
- Maruyama K, Sugano S (January 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. PMID 8125298.
- Law SK, Micklem KJ, Shaw JM, Zhang XP, Dong Y, Willis AC, Mason DY (September 1993). "A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily". European Journal of Immunology. 23 (9): 2320–5. S2CID 39770686.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (October 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. PMID 9373149.
- Droste A, Sorg C, Högger P (March 1999). "Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family". Biochemical and Biophysical Research Communications. 256 (1): 110–3. PMID 10066432.
- Ritter M, Buechler C, Langmann T, Schmitz G (July 1999). "Genomic organization and chromosomal localization of the human CD163 (M130) gene: a member of the scavenger receptor cysteine-rich superfamily". Biochemical and Biophysical Research Communications. 260 (2): 466–74. PMID 10403791.
- Van den Heuvel MM, Tensen CP, van As JH, Van den Berg TK, Fluitsma DM, Dijkstra CD, Döpp EA, Droste A, Van Gaalen FA, Sorg C, Högger P, Beelen RH (November 1999). "Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation". Journal of Leukocyte Biology. 66 (5): 858–66. S2CID 24504516.
- Buechler C, Ritter M, Orsó E, Langmann T, Klucken J, Schmitz G (January 2000). "Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli". Journal of Leukocyte Biology. 67 (1): 97–103. S2CID 9117014.
- Stover CM, Schleypen J, Grønlund J, Speicher MR, Schwaeble WJ, Holmskov U (2001). "Assignment of CD163B, the gene encoding M160, a novel scavenger receptor, to human chromosome 12p13.3 by in situ hybridization and somatic cell hybrid analysis". Cytogenetics and Cell Genetics. 90 (3–4): 246–7. S2CID 44704901.
- Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (January 2001). "Identification of the haemoglobin scavenger receptor". Nature. 409 (6817): 198–201. S2CID 205012693.
- Ritter M, Buechler C, Kapinsky M, Schmitz G (April 2001). "Interaction of CD163 with the regulatory subunit of casein kinase II (CKII) and dependence of CD163 signaling on CKII and protein kinase C". European Journal of Immunology. 31 (4): 999–1009. PMID 11298324.
- Sulahian TH, Hintz KA, Wardwell K, Guyre PM (June 2001). "Development of an ELISA to measure soluble CD163 in biological fluids". Journal of Immunological Methods. 252 (1–2): 25–31. PMID 11334962.
- Högger P, Sorg C (November 2001). "Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation". Biochemical and Biophysical Research Communications. 288 (4): 841–3. PMID 11688984.
- Fonseca JE, Edwards JC, Blades S, Goulding NJ (May 2002). "Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments". Arthritis and Rheumatism. 46 (5): 1210–6. PMID 12115225.
- Frings W, Dreier J, Sorg C (August 2002). "Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect". FEBS Letters. 526 (1–3): 93–6. S2CID 19660458.
- Matsushita N, Kashiwagi M, Wait R, Nagayoshi R, Nakamura M, Matsuda T, Hogger P, Guyre PM, Nagase H, Matsuyama T (October 2002). "Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3". Clinical and Experimental Immunology. 130 (1): 156–61. PMID 12296867.
External links
- CD163+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- Human CD163 genome location and CD163 gene details page in the UCSC Genome Browser.